Medicines in development for cancer in the United States 2020

Published by
Matej Mikulic,
Dec 19, 2022
This statistic represents the medicines in development for cancer in the United States as of year-end 2020. At that moment, most medicines in development concerning cancer were reported for solid tumors with a total of 527 medicines in development.

Medicines in development for cancer in the United States as of end-2020, by all types

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

December 2020

Region

United States

Survey time period

as of December 2020

Special properties

PhRMA members

Supplementary notes

Some medicines are listed in more than one category.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Prostate cancer in the U.S. "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Prostate cancer in the U.S.

Overview

4

Incidence

8

Survival rates

5

Deaths

7

Screening

3

Treatment

5

Further related statistics

18

Further Content: You might find this interesting as well

Statistics

Topics

Prostate cancer in the U.S.Cancer in the U.S.Skin cancer in the U.S.Breast cancer in the U.S.Men's health in the U.S.
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu